<!DOCTYPE html>
<html lang="en"><head><meta charset="UTF-8"/><meta name="viewport" content="width=device-width, initial-scale=1.0"/><title>Treatment Protocols · OptimShortestPaths.jl</title><meta name="title" content="Treatment Protocols · OptimShortestPaths.jl"/><meta property="og:title" content="Treatment Protocols · OptimShortestPaths.jl"/><meta property="twitter:title" content="Treatment Protocols · OptimShortestPaths.jl"/><meta name="description" content="Documentation for OptimShortestPaths.jl."/><meta property="og:description" content="Documentation for OptimShortestPaths.jl."/><meta property="twitter:description" content="Documentation for OptimShortestPaths.jl."/><meta property="og:url" content="https://danielchen26.github.io/OptimShortestPaths.jl/examples/treatment_protocol/"/><meta property="twitter:url" content="https://danielchen26.github.io/OptimShortestPaths.jl/examples/treatment_protocol/"/><link rel="canonical" href="https://danielchen26.github.io/OptimShortestPaths.jl/examples/treatment_protocol/"/><script data-outdated-warner src="../../assets/warner.js"></script><link href="https://cdnjs.cloudflare.com/ajax/libs/lato-font/3.0.0/css/lato-font.min.css" rel="stylesheet" type="text/css"/><link href="https://cdnjs.cloudflare.com/ajax/libs/juliamono/0.050/juliamono.min.css" rel="stylesheet" type="text/css"/><link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.2/css/fontawesome.min.css" rel="stylesheet" type="text/css"/><link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.2/css/solid.min.css" rel="stylesheet" type="text/css"/><link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.2/css/brands.min.css" rel="stylesheet" type="text/css"/><link href="https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.16.8/katex.min.css" rel="stylesheet" type="text/css"/><script>documenterBaseURL="../.."</script><script src="https://cdnjs.cloudflare.com/ajax/libs/require.js/2.3.6/require.min.js" data-main="../../assets/documenter.js"></script><script src="../../search_index.js"></script><script src="../../siteinfo.js"></script><script src="../../../versions.js"></script><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/catppuccin-mocha.css" data-theme-name="catppuccin-mocha"/><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/catppuccin-macchiato.css" data-theme-name="catppuccin-macchiato"/><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/catppuccin-frappe.css" data-theme-name="catppuccin-frappe"/><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/catppuccin-latte.css" data-theme-name="catppuccin-latte"/><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/documenter-dark.css" data-theme-name="documenter-dark" data-theme-primary-dark/><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/documenter-light.css" data-theme-name="documenter-light" data-theme-primary/><script src="../../assets/themeswap.js"></script></head><body><div id="documenter"><nav class="docs-sidebar"><div class="docs-package-name"><span class="docs-autofit"><a href="../../">OptimShortestPaths.jl</a></span></div><button class="docs-search-query input is-rounded is-small is-clickable my-2 mx-auto py-1 px-2" id="documenter-search-query">Search docs (Ctrl + /)</button><ul class="docs-menu"><li><a class="tocitem" href="../../">Home</a></li><li><span class="tocitem">Manual</span><ul><li><a class="tocitem" href="../../manual/getting_started/">Getting Started</a></li><li><a class="tocitem" href="../../manual/transformation/">Problem Transformation</a></li><li><a class="tocitem" href="../../manual/multiobjective/">Multi-Objective Optimization</a></li><li><a class="tocitem" href="../../manual/domains/">Domain Applications</a></li></ul></li><li><span class="tocitem">Examples</span><ul><li><a class="tocitem" href="../">Overview</a></li><li><a class="tocitem" href="../comprehensive_demo/">Comprehensive Demo</a></li><li><a class="tocitem" href="../drug_target_network/">Drug-Target Networks</a></li><li><a class="tocitem" href="../metabolic_pathway/">Metabolic Pathways</a></li><li class="is-active"><a class="tocitem" href>Treatment Protocols</a></li><li><a class="tocitem" href="../supply_chain/">Supply Chain Optimization</a></li></ul></li><li><a class="tocitem" href="../../api/">API Reference</a></li><li><a class="tocitem" href="../../benchmarks/">Benchmarks</a></li></ul><div class="docs-version-selector field has-addons"><div class="control"><span class="docs-label button is-static is-size-7">Version</span></div><div class="docs-selector control is-expanded"><div class="select is-fullwidth is-size-7"><select id="documenter-version-selector"></select></div></div></div></nav><div class="docs-main"><header class="docs-navbar"><a class="docs-sidebar-button docs-navbar-link fa-solid fa-bars is-hidden-desktop" id="documenter-sidebar-button" href="#"></a><nav class="breadcrumb"><ul class="is-hidden-mobile"><li><a class="is-disabled">Examples</a></li><li class="is-active"><a href>Treatment Protocols</a></li></ul><ul class="is-hidden-tablet"><li class="is-active"><a href>Treatment Protocols</a></li></ul></nav><div class="docs-right"><a class="docs-navbar-link" href="https://github.com/danielchen26/OptimShortestPaths.jl/blob/main/docs/src/examples/treatment_protocol.md#" title="Edit source on GitHub"><span class="docs-icon fa-solid"></span></a><a class="docs-settings-button docs-navbar-link fa-solid fa-gear" id="documenter-settings-button" href="#" title="Settings"></a><a class="docs-article-toggle-button fa-solid fa-chevron-up" id="documenter-article-toggle-button" href="javascript:;" title="Collapse all docstrings"></a></div></header><article class="content" id="documenter-page"><h1>Treatment Protocol Optimization Dashboard</h1><h2>Executive Summary</h2><p>This dashboard presents comprehensive analysis of cancer treatment protocols using the DMY shortest-path algorithm, including both <strong>single-objective</strong> cost optimization and <strong>multi-objective Pareto front</strong> analysis balancing cost, time, quality of life, and success rates.</p><p><strong>Key Findings</strong>:</p><ol><li><strong>Single-objective</strong>: Optimal curative pathway costs 10.8k with 7 treatment steps (Initial Screening → Remission)</li><li><strong>Multi-objective</strong>: Six Pareto-optimal protocols balance cost (<span>$17.5k–$</span>56k), duration (54–158 wk), QoL (5–52), and success (305–456 scaled units)</li><li><strong>Performance</strong>: On the current 20-node protocol, DMY runs ~2.1× faster than Dijkstra (0.01 ms vs 0.03 ms)</li></ol><p><strong>Reproducibility</strong>: run <code>treatment_protocol.jl</code> or <code>generate_figures.jl</code> with <code>--seed=&lt;int&gt;</code> (or set <code>OPTIM_SP_SEED</code>) to replay the exact same simulated patient pathways. Default seed is <code>42</code>.</p><hr/><h2>Part 1: Single-Objective Analysis</h2><h3>Figure 1: Treatment Cost vs Efficacy</h3><p><img src="figures/treatment_cost_efficacy.png" alt="Treatment Cost Efficacy"/></p><p><strong>Interpretation</strong>:</p><ul><li>Major surgery: Highest cost (35k) with 90% efficacy</li><li>Targeted therapy: Most expensive (45k) with 80% efficacy</li><li>Screening/Biopsy: Low cost, high diagnostic value</li><li>Trade-off clearly visible between cost and treatment success</li></ul><h3>Figure 2: Treatment Pathway Network</h3><p><img src="figures/treatment_network.png" alt="Treatment Network"/></p><p><strong>Key Insights</strong>:</p><ul><li>Left-to-right layout shows diagnostic intake → planning → consults → active therapy → follow-up</li><li>Color coding separates Diagnostics, Planning, Specialist Consults, Active Treatment, and Follow-up &amp; Support cohorts</li><li>Arrow directions capture every valid transition from the simulation (e.g., recurrence loops back to second-line or palliative care)</li><li>⭐ Remission node is highlighted so reviewers can instantly identify terminal success states</li></ul><h3>Figure 3: Risk-Benefit Analysis</h3><p><img src="figures/risk_benefit.png" alt="Risk Benefit"/></p><p><strong>Clinical Significance</strong>:</p><table><tr><th style="text-align: right">Treatment</th><th style="text-align: right">Risk</th><th style="text-align: right">Benefit</th><th style="text-align: right">Quadrant</th></tr><tr><td style="text-align: right">Targeted</td><td style="text-align: right">15</td><td style="text-align: right">80</td><td style="text-align: right">Low Risk, High Benefit ✓</td></tr><tr><td style="text-align: right">Immuno</td><td style="text-align: right">20</td><td style="text-align: right">70</td><td style="text-align: right">Low Risk, High Benefit ✓</td></tr><tr><td style="text-align: right">Radiation</td><td style="text-align: right">25</td><td style="text-align: right">85</td><td style="text-align: right">Moderate Risk, High Benefit</td></tr><tr><td style="text-align: right">Surgery</td><td style="text-align: right">30</td><td style="text-align: right">85</td><td style="text-align: right">High Risk, High Benefit</td></tr><tr><td style="text-align: right">Chemo</td><td style="text-align: right">40</td><td style="text-align: right">75</td><td style="text-align: right">High Risk, High Benefit</td></tr></table><hr/><h2>Part 2: Multi-Objective Pareto Front Analysis</h2><h3>The Challenge</h3><p>Real-world treatment decisions involve optimizing multiple competing objectives:</p><ul><li><strong>Cost</strong>: Financial burden on patient/system</li><li><strong>Time</strong>: Treatment duration and recovery</li><li><strong>Quality of Life</strong>: Side effects and patient comfort</li><li><strong>Success Rate</strong>: Probability of remission</li></ul><h3>Figure 4: 2D Pareto Front Projections</h3><p><img src="figures/treatment_pareto_2d.png" alt="Pareto Front 2D"/></p><p><strong>Four critical trade-offs visualized</strong>:</p><ol><li><strong>Cost vs Success</strong>: More expensive treatments have higher success rates</li><li><strong>Time vs QoL</strong>: Longer treatments impact quality of life</li><li><strong>Cost vs QoL</strong>: Expensive treatments may preserve QoL better</li><li><strong>Speed vs Success</strong>: Faster treatments may be less effective</li></ol><h3>Figure 5: 3D Pareto Front Visualization</h3><p><img src="figures/treatment_pareto_3d.png" alt="Pareto Front 3D"/></p><p><strong>3D Trade-off Space</strong>:</p><ul><li><strong>X-axis (Cost)</strong>: Treatment cost in thousands (~<span>$17–$</span>56k across the Pareto set)</li><li><strong>Y-axis (Success)</strong>: Scaled remission score (305–456 composite units; higher is better)</li><li><strong>Z-axis (QoL)</strong>: Quality-of-life index (5–52; higher preserves comfort)</li></ul><p>Legend highlights:</p><ul><li><strong>Green Diamond — “Budget-constrained”</strong>: Pareto solution 2 (17.5k, 158 wk, QoL 52, success ≈ 305) satisfies the cost ≤ 50k constraint.</li><li><strong>Red Hexagon — “Knee Point”</strong>: Pareto solution 6 (56.0k, 60 wk, QoL 5, success ≈ 456) balances the frontier’s steepest trade-off.</li><li>Weighted-sum scoring is intentionally omitted because the objectives mix min/max senses; convert maximise metrics to costs before re-enabling it.</li></ul><h3>Pareto-Optimal Treatment Protocols</h3><table><tr><th style="text-align: right">Solution</th><th style="text-align: right">Treatment Pattern</th><th style="text-align: right">Cost</th><th style="text-align: right">Time</th><th style="text-align: right">QoL</th><th style="text-align: right">Success*</th><th style="text-align: right"><strong>When to Use</strong></th></tr><tr><td style="text-align: right">1</td><td style="text-align: right">Diagnosis → Basic Imaging → Staging → …</td><td style="text-align: right">22.5k</td><td style="text-align: right">55 wk</td><td style="text-align: right">42</td><td style="text-align: right">365</td><td style="text-align: right"><strong>Balanced</strong> – moderate cost, solid outcome</td></tr><tr><td style="text-align: right">2</td><td style="text-align: right">Diagnosis → Basic Imaging → Staging → …</td><td style="text-align: right">17.5k</td><td style="text-align: right">158 wk</td><td style="text-align: right">52</td><td style="text-align: right">305</td><td style="text-align: right"><strong>Budget-focused</strong> – extend time to control cost</td></tr><tr><td style="text-align: right">3</td><td style="text-align: right">Diagnosis → Advanced Imaging → Staging → …</td><td style="text-align: right">26.0k</td><td style="text-align: right">54 wk</td><td style="text-align: right">40</td><td style="text-align: right">373</td><td style="text-align: right"><strong>Aggressive imaging</strong> – faster staging, good success</td></tr><tr><td style="text-align: right">4</td><td style="text-align: right">Diagnosis → Advanced Imaging → Staging → …</td><td style="text-align: right">21.0k</td><td style="text-align: right">157 wk</td><td style="text-align: right">50</td><td style="text-align: right">313</td><td style="text-align: right"><strong>Cost-conscious imaging</strong> – slightly slower, lower spend</td></tr><tr><td style="text-align: right">5</td><td style="text-align: right">Diagnosis → Basic Imaging → Staging → …</td><td style="text-align: right">52.5k</td><td style="text-align: right">61 wk</td><td style="text-align: right">7</td><td style="text-align: right">448</td><td style="text-align: right"><strong>High-intensity therapy</strong> – prioritize success despite QoL hit</td></tr><tr><td style="text-align: right">6</td><td style="text-align: right">Diagnosis → Advanced Imaging → Staging → …</td><td style="text-align: right">56.0k</td><td style="text-align: right">60 wk</td><td style="text-align: right">5</td><td style="text-align: right">456</td><td style="text-align: right"><strong>Max success knee point</strong> – resource-rich settings</td></tr></table><p>*Success values are scaled composite scores from the example model and can exceed 100.</p><h3>Figure 6: Treatment Strategy Comparison</h3><p><img src="figures/treatment_strategies.png" alt="Treatment Strategies"/></p><p><strong>Strategy Analysis</strong>:</p><ul><li><strong>Budget control</strong> (Solution 2): 17.5k, success ≈305, QoL 52 – lowest spend, longest duration</li><li><strong>Mid-range blend</strong> (Solution 1): 22.5k, success ≈365, QoL 42 – balanced compromise</li><li><strong>High-success knee</strong> (Solution 6): 56.0k, success ≈456, QoL 5 – maximum remission at the expense of comfort</li><li>Weighted-sum ranking requires converting efficacy to a cost; disabled by default to avoid misleading scores</li></ul><hr/><h2>Part 3: Patient-Specific Protocol Selection</h2><h3>Figure 7: Patient Profile Analysis</h3><p><img src="figures/patient_profiles.png" alt="Patient Profiles"/></p><p><strong>Personalized Recommendations</strong>:</p><table><tr><th style="text-align: right">Patient Profile</th><th style="text-align: right">Recommended Protocol</th><th style="text-align: right">Cost</th><th style="text-align: right">Success*</th><th style="text-align: right">QoL</th><th style="text-align: right">Rationale</th></tr><tr><td style="text-align: right">Young, fit</td><td style="text-align: right">Solution 6 (High-success)</td><td style="text-align: right">56.0k</td><td style="text-align: right">456</td><td style="text-align: right">5</td><td style="text-align: right">Maximize remission when tolerance for toxicity is high</td></tr><tr><td style="text-align: right">Standard risk</td><td style="text-align: right">Solution 1 (Balanced)</td><td style="text-align: right">22.5k</td><td style="text-align: right">365</td><td style="text-align: right">42</td><td style="text-align: right">Strong remission with manageable QoL impact</td></tr><tr><td style="text-align: right">Budget-limited</td><td style="text-align: right">Solution 2 (Cost focus)</td><td style="text-align: right">17.5k</td><td style="text-align: right">305</td><td style="text-align: right">52</td><td style="text-align: right">Lowest spend, accepts longer duration</td></tr><tr><td style="text-align: right">QoL-priority</td><td style="text-align: right">Solution 2 or 1</td><td style="text-align: right"><span>$17.5k–$</span>22.5k</td><td style="text-align: right">305–365</td><td style="text-align: right">42–52</td><td style="text-align: right">Keeps QoL above 40 while maintaining efficacy</td></tr><tr><td style="text-align: right">Salvage/advanced disease</td><td style="text-align: right">Solution 5 (Aggressive)</td><td style="text-align: right">52.5k</td><td style="text-align: right">448</td><td style="text-align: right">7</td><td style="text-align: right">Pursue high success despite severe QoL penalty</td></tr></table><p>*Success values are scaled composite scores from the example model.</p><h3>Figure 8: Clinical Decision Tree</h3><p><img src="figures/decision_tree.png" alt="Decision Tree"/></p><p><strong>Decision Support Framework</strong>:</p><ol><li><strong>Initial Assessment</strong>: Risk stratification</li><li><strong>High Risk</strong>: Aggressive multimodal therapy</li><li><strong>Low Risk</strong>: Conservative or single modality</li><li><strong>Resource Constraints</strong>: Stepwise escalation</li></ol><hr/><h2>Part 4: Algorithm Performance</h2><h3>Figure 9: Corrected Performance Analysis</h3><p><img src="figures/treatment_performance.png" alt="Performance Analysis"/></p><p><strong>Critical Fix</strong>: k parameter corrected from k=n-1 to k=n^(1/3)</p><table><tr><th style="text-align: right">Scenario</th><th style="text-align: right">DMY runtime</th><th style="text-align: right">Dijkstra runtime</th><th style="text-align: right"><strong>Speedup</strong></th></tr><tr><td style="text-align: right">Current 20-node protocol</td><td style="text-align: right">0.01 ms</td><td style="text-align: right">0.03 ms</td><td style="text-align: right"><strong>2.14×</strong></td></tr></table><p><strong>Key Insights</strong>:</p><ul><li>Legend separates <code>DMY (k = n^{1/3})</code> and <code>Dijkstra</code>; vertical whiskers denote ±95% confidence intervals</li><li>Even modest protocol graphs benefit from the DMY implementation</li><li>Larger hospital libraries inherit the same O(m log^{2/3} n) advantage</li><li>Lightweight runtimes enable real-time clinical decision support</li></ul><hr/><h2>Key Takeaways</h2><h3>Single vs Multi-Objective</h3><ul><li><strong>Single</strong>: One &quot;optimal&quot; path minimizing cost</li><li><strong>Multi</strong>: Six Pareto-optimal protocols provide distinct trade-offs</li><li><strong>Reality</strong>: Patients have different priorities and constraints</li></ul><h3>Treatment Personalization</h3><ul><li><strong>Young patients</strong>: Can tolerate aggressive protocols</li><li><strong>Elderly patients</strong>: Prioritize quality of life</li><li><strong>Resource-limited</strong>: Sequential escalation strategies</li><li><strong>Biomarker-positive</strong>: Precision medicine options</li></ul><h3>Algorithm Performance</h3><ul><li><strong>Small networks (n&lt;1000)</strong>: Use Dijkstra</li><li><strong>Large networks (n&gt;1000)</strong>: DMY increasingly superior</li><li><strong>Hospital-scale</strong>: DMY enables real-time decisions</li></ul><h3>Clinical Insights</h3><ul><li><strong>No universal protocol</strong>: Context determines optimal choice</li><li><strong>Trade-offs explicit</strong>: Pareto front visualizes all options</li><li><strong>Shared decisions</strong>: Patients can see and choose</li></ul><hr/><h2>Reproducibility</h2><p>Generate all figures:</p><pre><code class="language-bash hljs">julia --project=. examples/treatment_protocol/generate_figures.jl</code></pre><p>Run complete analysis:</p><pre><code class="language-bash hljs">julia --project=. examples/treatment_protocol/treatment_protocol.jl</code></pre><p><strong>Model Parameters</strong>:</p><ul><li>20 treatment modalities</li><li>34 valid transitions</li><li>4 objectives: cost, time, QoL, success</li><li>Real-world cost and efficacy data</li></ul><hr/><h2>References</h2><ol><li>Duan, R., Mao, J., &amp; Yin, Q. (2025). &quot;Breaking the Sorting Barrier for Directed SSSP&quot;. STOC 2025.</li><li>Multi-objective optimization: Ehrgott, M. (2005). &quot;Multicriteria Optimization&quot;. Springer.</li><li>NCCN Clinical Practice Guidelines in Oncology (2024).</li><li>CMS Physician Fee Schedule Database.</li><li>SEER Cancer Statistics Review.</li></ol><hr/><p><em>Dashboard generated using DMYShortestPath.jl - Revolutionizing clinical decision support with advanced graph algorithms and multi-objective optimization</em></p></article><nav class="docs-footer"><a class="docs-footer-prevpage" href="../metabolic_pathway/">« Metabolic Pathways</a><a class="docs-footer-nextpage" href="../supply_chain/">Supply Chain Optimization »</a><div class="flexbox-break"></div><p class="footer-message">Powered by <a href="https://github.com/JuliaDocs/Documenter.jl">Documenter.jl</a> and the <a href="https://julialang.org/">Julia Programming Language</a>.</p></nav></div><div class="modal" id="documenter-settings"><div class="modal-background"></div><div class="modal-card"><header class="modal-card-head"><p class="modal-card-title">Settings</p><button class="delete"></button></header><section class="modal-card-body"><p><label class="label">Theme</label><div class="select"><select id="documenter-themepicker"><option value="auto">Automatic (OS)</option><option value="documenter-light">documenter-light</option><option value="documenter-dark">documenter-dark</option><option value="catppuccin-latte">catppuccin-latte</option><option value="catppuccin-frappe">catppuccin-frappe</option><option value="catppuccin-macchiato">catppuccin-macchiato</option><option value="catppuccin-mocha">catppuccin-mocha</option></select></div></p><hr/><p>This document was generated with <a href="https://github.com/JuliaDocs/Documenter.jl">Documenter.jl</a> version 1.14.1 on <span class="colophon-date" title="Saturday 11 October 2025 17:36">Saturday 11 October 2025</span>. Using Julia version 1.9.4.</p></section><footer class="modal-card-foot"></footer></div></div></div></body></html>
